Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Median overall survival of 23.7 months following CMB305 monotherapy represents approximately one-year extension of ...
Senior pharmaceutical executives with extensive experience in immuno-oncology, drug development, commercializing oncology medications and ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email